We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.26B
AUM Growth
+$69.7M
Cap. Flow
+$21.1M
Cap. Flow %
1.68%
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.54M
2
MNST icon
Monster Beverage
MNST
+$3.4M
3
UGI icon
UGI
UGI
+$3.25M
4
LMND icon
Lemonade
LMND
+$3.18M
5
APA icon
APA Corp
APA
+$3.05M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$4.73M
2
AON icon
Aon
AON
+$4.58M
3
ZG icon
Zillow
ZG
+$4.44M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$4.08M
5
BWXT icon
BWX Technologies
BWXT
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 12.61%
3 Healthcare 12.06%
4 Consumer Discretionary 11.89%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KODK icon
1526
Kodak
KODK
$983M
$59K ﹤0.01%
12,001
-121,010
-91% -$486K
LLAP
1527
DELISTED
Terran Orbital Corporation
LLAP
$58K ﹤0.01%
+44,322
New +$44.8K
AMWL icon
1528
American Well
AMWL
$230M
$57K ﹤0.01%
3,503
-17,589
-83% -$377K
CBIO
1529
Crescent Biopharma
CBIO
$626M
$55K ﹤0.01%
183
-1,827
-91% -$546K
VIP
1530
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37.2M
$55K ﹤0.01%
15,850
-43,536
-73% -$179K
MSS icon
1531
Maison Solutions
MSS
$1.11M
$54K ﹤0.01%
+795
New +$49.6K
NGM
1532
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$53K ﹤0.01%
33,529
-300,944
-90% -$446K
GSAT icon
1533
Globalstar
GSAT
$10.8B
$50K ﹤0.01%
+2,265
New +$54.8K
CVM icon
1534
CEL-SCI Corp
CVM
$30.1M
$49K ﹤0.01%
+852
New +$60.3K
SPRO icon
1535
Spero Therapeutics
SPRO
$73M
$49K ﹤0.01%
+28,319
New +$44.4K
GTHX
1536
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$47K ﹤0.01%
10,774
-15,243
-59% -$53.1K
TRVG
1537
trivago
TRVG
$397M
$46K ﹤0.01%
16,711
+78
+0.5% +$197
DC icon
1538
Dakota Gold
DC
$804M
$43K ﹤0.01%
+18,040
New +$39K
PDSB icon
1539
PDS Biotechnology
PDSB
$43.4M
$41K ﹤0.01%
+10,358
New +$53.4K
SMRT icon
1540
SmartRent
SMRT
$272M
$41K ﹤0.01%
15,240
-70,110
-82% -$203K
TVRD
1541
Tvardi Therapeutics
TVRD
$23.4M
$41K ﹤0.01%
1,257
-4,998
-80% -$130K
ZOM
1542
DELISTED
Zomedica Corp.
ZOM
$36K ﹤0.01%
+244,987
New +$34.3K
SCYX icon
1543
SCYNEXIS
SCYX
$52M
$35K ﹤0.01%
2,937
-1,699
-37% -$24K
CVAC
1544
DELISTED
CureVac
CVAC
$31K ﹤0.01%
+10,335
New +$36.3K
FSP
1545
Franklin Street Properties
FSP
$46.8M
$29K ﹤0.01%
12,758
-188,352
-94% -$449K
ATAI icon
1546
AtaiBeckley Inc
ATAI
$2.68B
$28K ﹤0.01%
+14,431
New +$26.6K
HGBL icon
1547
Heritage Global
HGBL
$36.8M
$27K ﹤0.01%
+10,190
New +$29K
LUXH
1548
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$27K ﹤0.01%
+284
New +$68.4K
LVO icon
1549
LiveOne
LVO
$58.2M
$26K ﹤0.01%
+1,345
New +$21.4K
XERS icon
1550
Xeris Biopharma Holdings
XERS
$1.45B
$26K ﹤0.01%
11,711
-404,556
-97% -$1.05M
60 61
62
63 64

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, GSA Capital Partners held 2,074 positions worth $1.26B, up 5.9% from $1.19B the previous quarter. Its ten largest holdings account for 3.2% of the portfolio.

GSA Capital Partners's Q1 2024 filing shows 640 new, 457 increased, 456 reduced and 520 closed positions. Its largest new stake was Zoetis: 18,907 shares worth $3.2M. The largest sale was CRH, an estimated $4.73M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • GSA Capital Partners's largest Q1 2024 buy was Zoetis: 18,907 shares worth $3.2M.
  • GSA Capital Partners added most to Monster Beverage in Q1 2024, an estimated $3.4M increase.
  • GSA Capital Partners's biggest Q1 2024 reduction was CRH, cutting an estimated $4.73M.
  • GSA Capital Partners fully exited Aon in Q1 2024, selling an estimated $4.58M.
  • GSA Capital Partners's ten largest holdings make up 3.2% of its $1.26B portfolio in Q1 2024.
  • GSA Capital Partners opened 640 new positions and closed 520 in Q1 2024.
  • GSA Capital Partners's portfolio value rose 5.9% quarter-over-quarter to $1.26B.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.